New drug combo aims to shrink Hard-to-Treat tumors
Disease control
Recruiting now
This study tests a new drug called LCB84, which targets a protein (TROP2) on cancer cells, in people with advanced solid tumors that have not responded to standard treatments. The drug is given alone or with an immunotherapy (anti-PD-1) to see if it is safe and can shrink tumors.…
Phase: PHASE1, PHASE2 • Sponsor: LigaChem Biosciences, Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC